Abbott Laboratories (ABT)EXECUTIVE VICE PRESIDENT sold ~$3.05M

~$3.05M

Approx. value · 24K sh @ $128.50

126K

Holds after · shares reported

Traded

Jan 30, 2025

Filed

Feb 1, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 11, 2024CongressDisclosed partial sale of ABT — reported range $15,001 - $50,000
2. Dec 16, 2024CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
3. Jan 6, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
4. Jan 8, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
5. Jan 15, 2025Congress · 1 personMembers of Congress: 3 sales
6. Jan 28, 2025InsiderOfficer sold ~$337K of ABT shares in the open market
7. Jan 28, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
8. Jan 29, 2025InsiderOfficer sold ~$16.9M of ABT shares in the open market
9. Jan 29, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
10. Jan 30, 2025 · this disclosureInsiderOfficer sold ~$3.05M of ABT shares in the open market

What came next

1. Jan 30, 2025InsiderOfficer sold ~$7.48M of ABT shares in the open market
2. Feb 5, 2025InsiderCEO sold ~$37.4M of ABT shares in the open market
3. Feb 13, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
4. Feb 24, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
5. Mar 3, 2025Insider · 5 peopleInsiders: 5 sales (~$549K)
6. Mar 3, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
7. Mar 6, 2025InsiderOfficer sold ~$12.2M of ABT shares in the open market
8. Mar 6, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
9. Mar 7, 2025InsiderOfficer sold ~$27K of ABT shares in the open market
10. Mar 18, 2025FDARecall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08H67-01 Software Version: All software versions Product Description: CELL-DYN Ruby…
11. Mar 18, 2025FDARecall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08H67-10 Software Version: All software versions Product Description: CELL-DYN Ruby…
12. Mar 18, 2025FDARecall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08H67-13 Software Version: All software versions Product Description: CELL-DYN Ruby…
13. Mar 18, 2025FDARecall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 04U42-84 Software Version: All software versions Product Description: CELL-DYN Ruby
14. Mar 18, 2025FDARecall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08H67-03 Software Version: All software versions Product Description: CELL-DYN Ruby…
15. Mar 20, 2025FDARecall: The Alinity m System is designed to automate the steps for nucleic acid testing. Model Numbers included in this recall are 08N53-001, 08N53-002, and 08N53-032…
16. Mar 20, 2025Congress · 1 personMembers of Congress: 2 purchases
17. Mar 24, 2025FDAFDA device clearance: Alinity m BKV
18. Apr 4, 2025FDAFDA device clearance: JETi Hydrodynamic Thrombectomy System
19. Apr 21, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
20. Apr 25, 2025FDAFDA device clearance: Amulet™ Steerable Delivery Sheath

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 82 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Daniel Gesua Sive Salvadori, EXECUTIVE VICE PRESIDENT

• SEC Form 4 at Abbott Laboratories (ABT)Mar 4, 2026

The full history of Daniel Gesua Sive Salvadori, EXECUTIVE VICE PRESIDENT is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Abbott Laboratories

• SEC Form 4Sep 3, 2026
• SEC Form 144Sep 2, 2026
• SEC Form 4Aug 27, 2026
• SEC Form 4Aug 27, 2026
• SEC Form 13F-HRAug 26, 2026
• SEC Form 13F-HRAug 20, 2026

Everything OQRO holds on this company is on its ABT page.